Halo Neuroscience CEO talks about its dual approach to the neurostimulation market
Daniel Chao, who previously co-founded NeuroPace, said unlike most startups, the company didn't have a specific product in mind when it launched in 2013.
Halo Neuroscience raises $9M Series A for neurostimulation for athletics, stroke rehab
Lux Capital led the round with participation from Andreessen Horowitz, Jazz Venture Partners, SoftTech Ventures and Xfund.
presented by
Price Transparency is the New North in the PBM World
In this episode hear how improving benefit verification, prior authorizations, and patient affordability with smart integrations and real-time eligibility can streamline healthcare workflows.